Dec 09, 2019: EtectRx® Inc. announced U.S. Food and Drug Administration (FDA) clearance of its breakthrough patented ingestible event marker, the ID-Cap® System (first and only ingestible event marker) in order to transmit digital messages from within the body to an external receiver not including the need for direct skin contact for the purpose of recording ingestion events.
Comprised of ID-Capsule, ID-Tag, ID-Cap Reader, and related software, the ID-Cap System provides real-time, dose-level ingestion event verification.
The ID-Cap Reader (worn on a lanyard) verifies the message as a valid ingestion event and forwards the data to a secure smartphone-based mobile application and to the healthcare provider in a very secure web-based portal.
This is a momentous event for etectRx and the larger digital health market.
EtectRx collaborates with key stakeholders, including healthcare providers, health systems, pharmacies, pharmaceutical manufacturers, and clinical research organizations, in order to bring this innovative technology to digital medications of the future and other valuable applications in the medical, pharmaceutical, and consumer markets. https://etectrx.com/etectrx-announces-u-s-fda-clearance-of-novel-ingestible-event-marker/
